Case File
efta-efta00740188DOJ Data Set 9OtherDS9 Document EFTA00740188
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00740188
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: "Jeffrey Epstein" <[email protected]>
Subject: Fw: China Outbound
Date: Sat, 17 Jul 2010 17:17:40 +0000
Importance: Normal
Original Message
From: Joe Sealy ‹
>
Date: Sat, 17 Jul 2010 17:08:58
To:
Cc: Ketan
Crispino
Subject: Re: China Outbound
; Francis
David
We have amended our deal by deal proposal to create a performance driven commercial
relationship between us.
Regarding the fund economics, as you know we have very experienced professionals working with
us on the terms we have offered you, setting up new divisions with us . This position may
change over time. At this stage however we are not ready as an organisation to change this.
So, if our proposal is unsatisfactory to you, we should not proceed.
Safe travels.
Joe
Original Message
From:
"c
>
To: Joe Sealy
Cc: Ketan Patel; Francis Crispino
Sent: Sat Jul 17 15:32:25 2010
Subject: Re: China Outbound
Joe
Many thanks for your reply, I am now on a train from Beijing to Lhasa which will mean limited
email access once we hit 3000m. Therefore as quick question: the long term fund economics are
important and therefore will your position re the carry position remain (me + team 30% and
GPC 70%)? This will in principle not work, so how do you propose this may be adjusted? It was
my understanding that you require some binding commitment that when deal One is successfully
executed, we move to the dedicated fund that I will manage? If so, the fund terms must be
clarified now in principle so we are on the same page.
All the best
David
Original Message
From: Joe Sealy ‹
>
Date: Fri, 16 Jul 2010 01:48:39
To:
Cc: Ketan Patel
; Francis
Crispino
Subject: Re: China Outbound
David
Thanks for your note.
There are two sets of issues you raise. The first, with respect to economics, we have
focused on the deal by deal economics. Reflecting on our last discussion on how to create a
performance driven commercial relationship, we would propose the following economics:
* 3% base per deal for deals accepted. Increments take this to:
* 25% for deals accepted delivering >3x in 1 year.
* 15% for deals accepted delivering 2-3x in 1 year.
* 5% for deals accepted delivering >2x in 2 years. 10% if that exceeds 4x.Target deal size:
>$100m. (Smaller deals at our discretion).
EFTA00740188
We have already discussed our differences regarding the longer term fund economics and so we
should not consider this proposition at this time.
The second issue you raise with respect to governance and decision-making we have not really
discussed. However, our intention has not changed from the desire to create an innovative and
entrepreneurial venture to unlock unique China outbound opportunities. We clearly need to
kick this around to agree how we can achieve this by working together
Hopefully, this clarifies our position. We are of course happy to discuss further.
Regards
Joe
Original Message
From:
<
›
To: Joe Sealy
Cc: Ketan Patel; Francis Crispino
Sent: Thu Jul 15 15:51:20 2010
Subject: China Outbound
Joe,
As per our last conversation I wanted to give you feedback. Since I have had no further
comments from you re the GPC side my current view is as follows:
- you stated that there is a disconnect and I agree this is the case on some items
- I still fail to see the entrepreneurial side and see a structure with little control or
decision making
- the deals I generate will go to you and once executed I end up with little. Were I take my
deals and "shop them around" to potential investors in my network would not get better terms?
- you mentioned several times that there is a disconnect on the terms. While I thought based
on our meeting with Ketan we can discuss these issues it seems that GPC is fixed on the terms
which do not work for me, even though - as you stated - more experienced managers accept
them. The deals (if they were to work which of course I do not know yet...) would be
groundbreaking and open a new playing field
- another disconnect which is my fault in failing to explain, is your key point that the GPC
platform will allow you to raise a dedicated fund following a first successful deal. The
capital and fundraising is not why I came to GPC and I believe strongly that I can get all
required capital from my sources, especially after deal One.
Considering these points and terms offered which unfortunately do not work for me at this
stage, we either discuss a different way of collaboration or revisit ways of partnership in
the future once I made substantial progress on this new business. Please let me know your
views.
Many thanks
David
EFTA00740189
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Wire Ref
ReflectingRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.